- Investor's Business Daily•4 days ago
Biotechs have a lot riding on drug data in 2017 with nearly two dozen firms reporting data in four key segments.
- GlobeNewswire•7 days ago
WALTHAM, Mass., Jan. 17, 2017-- TESARO, Inc., an oncology-focused biopharmaceutical company, today announced the opening of an expanded access program in the United States for the investigational PARP ...
- Investor's Business Daily•11 days ago
What should investors take away from the JPMorgan Healthcare Conference? Sentiment is "cautiously optimistic."
TSRO : Summary for TESARO, Inc. - Yahoo Finance
Tesaro, Inc. (TSRO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||141.50 x 200|
|Ask||149.10 x 300|
|Day's Range||141.61 - 148.53|
|52 Week Range||29.51 - 157.77|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-19.46|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|